Literature DB >> 3419596

Risk factors for progressive supranuclear palsy.

P H Davis1, L I Golbe, R C Duvoisin, B S Schoenberg.   

Abstract

To explore possible risk factors for progressive supranuclear palsy (PSP), we conducted a case-control study of 50 cases in New Jersey. Two neurologists confirmed the diagnosis in the 41 living patients. Two hospital controls were matched by age, sex, race, date of death, and relationship of next-to-kin to each case. A structured interview was administered in person to the next-of-kin of cases and controls. Genetic, viral, toxic, medical, surgical, and personality factors were investigated. Cases lived in areas with low population as adults significantly more frequently than controls. The study identified no other factors associated with PSP including a history of stroke, hypertension, or smoking.

Entities:  

Mesh:

Year:  1988        PMID: 3419596     DOI: 10.1212/wnl.38.10.1546

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Progressive supranuclear palsy.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

Review 2.  Progressive supranuclear palsy (Steele-Richardson-Olszewski disease).

Authors:  H R Morris; N W Wood; A J Lees
Journal:  Postgrad Med J       Date:  1999-10       Impact factor: 2.401

Review 3.  Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  J Mol Neurosci       Date:  2011-06-08       Impact factor: 3.444

Review 4.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.

Authors:  Irene Litvan; Peter S J Lees; Christopher R Cunningham; Shesh N Rai; Alexander C Cambon; David G Standaert; Connie Marras; Jorge Juncos; David Riley; Stephen Reich; Deborah Hall; Benzi Kluger; Yvette Bordelon; David R Shprecher
Journal:  Mov Disord       Date:  2016-02-08       Impact factor: 10.338

Review 6.  Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.

Authors:  D W Dickson
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

7.  Progressive Supranuclear Palsy.

Authors:  Lawrence I. Golbe
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

8.  Familial progressive supranuclear palsy.

Authors:  J Brown; P Lantos; M Stratton; P Roques; M Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

Review 9.  Neurodegenerative diseases: an overview of environmental risk factors.

Authors:  Rebecca C Brown; Alan H Lockwood; Babasaheb R Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

10.  Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database.

Authors:  Emma Viscidi; Irene Litvan; Tien Dam; Maneesh Juneja; Li Li; Henry Krzywy; Susan Eaton; Susan Hall; Joseph Kupferman; Günter U Höglinger
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.